Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001567619-22-019426
Filing Date
2022-11-10
Accepted
2022-11-10 09:23:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G/A 64765
  Complete submission text file 0001567619-22-019426.txt   66568
Mailing Address 25 EAST ERIE ST CHICAGO IL 60611
Business Address 25 EAST ERIE ST CHICAGO IL 60611 3125873800
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000938206 (see all company filings)

IRS No.: 203634295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92879 | Film No.: 221375304
SIC: 2834 Pharmaceutical Preparations